Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show

Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show

Source: 
Stat
snippet: 

A year and a half after the opioid painkiller OxyContin went on the market, a Purdue Pharma sales representative documented a physician’s concern about the burgeoning drug that would come up again and again.

“Dr worried re addiction w/ Oxy,” the sales rep wrote in a memo summarizing a visit with a Kentucky physician on Aug. 12, 1997.